Fee for Service–Part of the problem

We have perverse incentives that increase utilization and health care costs. Consider this:

“Millions of patients each year leave the hospital only to return within weeks or months for lack of proper follow-up care.”

“In fact, because insurers typically pay hospitals to treat patients – not to keep them away by keeping them healthy – hospitals can actually lose money by providing better care. Empty beds mean lost revenue.”

The question is how to align incentives to encourage prevention, efficiency and quality care.

Powered by Zoundry Raven

Swine Flu–Walking and Chewing Gum

  • Thus far the swine flu epidemic has been manageable. 42 deaths in Mexico, two in the U.S., but mostly a reasonably mild disease for the great majority of those affected. Cases will continue but for now as the flu season winds down the epidemic seems manageable. From the WHO:

“23 countries have officially reported 2099 cases of influenza A(H1N1) infection.”

“Mexico has reported 1112 laboratory confirmed human cases of infection, including 42 deaths. The United States has reported 642 laboratory confirmed human cases, including two deaths.”

“The following countries have reported laboratory confirmed cases with no deaths – Austria (1), Canada (201), China, Hong Kong Special Administrative Region (1), Colombia (1), Costa Rica (1), Denmark (1), El Salvador (2), France (5), Germany (9), Guatemala (1), Ireland (1), Israel (4), Italy (5), Netherlands (1), New Zealand (5), Portugal (1), Republic of Korea (2), Spain (73), Sweden (1), Switzerland (1) and the United Kingdom (28).”

In the 1918 epidemic there were episodes of relatively minor disease that were later followed by periods of very virulent disease with explosive spread. The disease altered evolved or perhaps creationed itself (see this) into more dangerous forms which caused a rapidly progressing severe illness, killing millions. This could still happen.

We have some time to develop a vaccine and strategies for more severe disease should they occur. This from Science, May 1:

“Early on, CDC began to brew a “seed” strain for a possible vaccine against swine H1N1, and by 27 April the World Health Organization in Geneva, Switzerland, was already talking to vaccine manufacturers. One key problem is that the world’s influenza vaccine production capacity-which still relies on growing the vaccine virus in chicken eggs-is limited to some 400 million vaccine doses a year and is impossible to expand quickly. Manufacturing swine flu vaccine would thus come at the expense of seasonal vaccine production, says retired pharma executive and flu vaccine expert David Fedson, and might lead to higher mortality and morbidity from the three seasonal strains.For now, WHO says manufacturers should continue preparing vaccine for the 2009-10 flu season. But that could change if swineflu proves particularly severe. “We’re in a casino now, and we’re placing our bets,” says Fedson.”

Powered by Zoundry Raven

Health Savings Accounts–Where are the Savings?

  1. David Ignatius notes:

“He found that for the 53 percent of households that hold at least one retirement account, the median combined balance was a mere $45,000.”

“Hold on, you say, that figure includes some younger workers who haven’t started saving in earnest yet. Okay, for households headed by persons between the ages of 55 and 64, the median value of all retirement accounts was just $100,000. Purcell noted that for a 65-year-old man retiring last month, that $100,000 would buy an annuity that would pay a paltry $700 a month for life, based on current interest rates.”

This in the generation that has lived through what is arguably the most prosperous era of our country’s history.

Meanwhile:

“Fidelity Investments says a 65-year-old couple retiring in 2008 will need approximately $225,000 to cover medical costs in retirement. That doesn’t even include over-the-counter medications, most dental services, and long-term care. The Employee Benefit Research Institute figures a married couple will need a staggering $305,000, just to have a 90 percent chance of being able to pay for all out-of-pocket retirement health expenses (the money could be paid in part out of retirement income, however.)”

Medicynical Note: Proponents of HSA’s (Health Savings Accounts) and other high deductible health insurance schemes say paying for health care is easy. Simply have people use health savings accounts to put aside money for the times when they need it. The problem is that during the most financially remunerative era in our history savings of any type didn’t occur. Moreover, the health of our economy depended on low savings rates to spur consumption.

Something’s wrong here. HSA’s and such engage in magical thinking rather than serious problem solving. They are recipes for disaster. We need to find better ways to control health costs and pay for them.

Powered by Zoundry Raven

Our Consitutional Rights–The World must be puzzled!

This report from USA today notes a Federal Judge ruling that disparaging remarks regarding creationism is an infringement on a student’s 1st amendment rights.  

He ruled that depicting:

“creationism as “religious, superstitious nonsense,” did violate Farnan’s constitutional rights.”

Medicynical note: I wasn’t aware the Constitution protected nonsensical beliefs.

Powered by Zoundry Raven

Colonic cleansing–Nonsense, Nonsense, Nonsense

There seem to be innumerable products on the market that tout the benefit of “detoxification” and the idea that wastes build up in the colon and need cleansing. This is the basis of the widely used naturopathic remedy of colonic irrigation and various detox forumulas.

Consumer’s reports notes:

“We found insufficient reliable evidence that colon-cleansing products are safe or effective for improving general health. But we did find some cause for concern. When they are administered too often, laxatives and enemas might prevent normal bowel movements or lead to a potentially deadly depletion of vital electrolytes.”

And regarding waste accumulation:

“Waste does not accumulate in firm masses on intestinal walls, spreading toxins into the bloodstream, says Mark DeLegge, M.D., a spokesman for the American Gastroenterological Association in Bethesda, Md. He suggests staying regular by eating foods that are rich in fiber, including vegetables (broccoli, carrots, spinach, and squash), fruits (apples, bananas, and pears), whole grains (barley, whole or rolled oats, and whole wheat), and legumes (beans, lentils, peanuts, and peas).”

Medicynical note: Quackery has endless variations.

Powered by Zoundry Raven

Cheap Health Insurance–Why the industry needs regulation

The notion that the market will provide efficient, quality health insurance is a figment of the same imagination that brought us gimmicky mortgages, derivatives and credit default swaps.

Some horror stories in the Seattle PI (website paper):

“We read everything, and it looked like it was really good,”

“But a year later, his wife underwent surgery and Stewart was saddled with $20,000 in medical bills. He has been quarreling since with the insurance company, which said his wife had a pre-existing condition.”

“a Bainbridge Island woman sued her insurance company, alleging that it misled her into thinking she had comprehensive coverage only to later burden her with $135,000 in bills.”

Average consumers cannot fully understand the strengths and limitations of proffered policies. Asking them to do so opens the door to all types of abuses a noted above. Policies have contingencies that people don’t fully understand. Deductibles expressed as per cent of fees sound reasonable until one is confronted with $100,000 or more in bills.

Medicynical note: We need standardized policies with equal benefit structures. Companies would compete on the quality of services, amount of deductibles and copays, and the efficiency of their administrative services.

Powered by Zoundry Raven

Drug Company Gifts: Conflicts of Interest

Gifts from drug companies to doctors continue despite reports to the contrary. Companies claim that such gifts are ethical and necessary. The NY Times notes:

“Drug companies spend billions (medicynical emphasis) of dollars wooing doctors – more than they spend on research or consumer advertising. Much of this money is spent on giving doctors free drug samples, free food, free medical refresher courses and payments for marketing lectures. The institute’s report recommends that nearly all of these efforts end.”

Imagine the cost savings to consumers if drug companies spent less on marketing. These companies claim it takes $800,000,000 to bring a new drug to market. How much of this inflated figure is gifts to doctors aimed an influencing their treatment decisions? If we presume the NY Times is correct and more is spent on gifts and advertising then research then the real cost of new drugs is significantly less than companies claim. Guess who ultimately pays for all this?

With drug prices increasing faster than any other part of health care expenditures is it too much to ask, as the IOM (Institute of Medicine) does, that companies and docs forgo this unethical practice?

Powered by Zoundry Raven

Swine flu–The Real Thing?

  • Current Status of the epidemic:

Mexico: almost 2000 suspected infections, 152 suspected deaths from swine flu – 20 confirmed deaths,

US: 50 confirmed cases (Ohio 1 case, Kansas 2 cases, Texas 2 cases, New York 28 cases and California 7 cases)

Canada: 6 confirmed cases

New Zealand – 3 confirmed cases

UK – 2 confirmed cases

Spain- 2 confirmed cases

Israel – 1 confirmed case

Countries with suspected cases: Brazil, Guatemala, Peru, Australia, and South Korea, and seven EU states

This outbreak, more here and here, has potential for a pandemic, an event anticipated and feared by infectious disease epidemiologists for the last 80 years. A H1N1 virus (similar to the causative agent of the1918 epidemic) has jumped from swine to man and has shown the ability to pass through several generations of infected individuals.

WHO deputy chief Keiji Fukuda said this was a “significant step towards pandemic influenza” but a pandemic should not be considered inevitable.

“Hugh Pennington, a leading bacteriologist in the UK, said on Tuesday that it was difficult to make any predictions about the outbreak because of its nature. It’s a new virus – we’ve never before seen this combination of swine virus and human virus genes,”

What can be presumed at present:

1. If the disease spreads worldwide, there will be excess mortality. As bad as the 1918 episode, not so far. We don’t have enough information to estimate mortality rates. Of interest was the severity of the disease in 1918 among younger groups. That implied residual immunity from earlier viral disease exposure that protected the elderly. It’s too early to tell whether there will be a similar pattern with the current problem.

Watch out for the disease in overpopulated areas. In 1918 the world’s population was 1.8 billion and the virus killed over 50 million people. Our population now is approaching 7 billion.

2. The severity of the disease is unclear. In Mexico mortality appears significantly higher than elsewhere, so far. This may be deceptive if the cases we know of represent a small part of those infected–the rest with minor upper respiratory disease. (as implied in this Guardian article) Alternatively, the Mexican experience may represent a virus with more severe ramifications that altered pathogenicity with passage through succeeding generations of infected people. A question of great concern is whether a more pathogenic strain will emerge. In 1918, there were periods when the virus appeared to be less severe and then abruptly changed. We’re still not sure what happened then but it’s possible, perhaps likely, that a similar course can occur now.

3. Those with impaired immune systems will be particularly vulnerable.

5. The CDC notes regarding antiviral drugs: ”

“There are four influenza antiviral drugs approved for use in the United States (oseltamivir, zanamivir, amantadine and rimantadine). The swine influenza A (H1N1) viruses that have been detected in humans in the United States and Mexico are resistant to amantadine and rimantadine so these drugs will not work against these swine influenza viruses. Laboratory testing on these swine influenza A (H1N1) viruses so far indicate that they are susceptible (sensitive) to oseltamivir and zanamivir.”

While oseltamivir (Tamiflu) and zanamivir (Relenza) may have activity in lab settings, there is no information yet whether they will prevent complications or mortality in actual patients.

CDC does recommend:

Treatment: If you get sick, antiviral drugs can make your illness milder and make you feel better faster. They may also prevent serious influenza complications. For treatment, antiviral drugs work best if started as soon after getting sick as possible, and might not work if started more than 48 hours after illness starts.”

Prevention: Influenza antiviral drugs also can be used to prevent influenza when they are given to a person who is not ill, but who has been or may be near a person with swine influenza. When used to prevent the flu, antiviral drugs are about 70% to 90% effective. When used for prevention, the number of days that they should be used will vary depending on a person’s particular situation.”

6. Vaccine development and testing will take some time, at least 4 months, probably more.

Powered by Zoundry Raven

Epidemic Influenza (The New Swine Flu)

Some are wondering why the new flu has emerged. I’ve seen questions about whether it was “manufactured.” But when something occurs that has been expected for many years why should we jump first to paranoid ideation?

Look at CDC info here and  here or try  the book “The Great Influenza: The Epic Story of the Greatest Plague” by John Barry for info.

The epidemic of 1918 occurred in the context of WW I during which large groups of susceptible people were thrown together in training and on ships going to war. The virus’s pathogenicity varied as it passed through generations of patients.

What will happen with the current epidemic will depend on how effectively we mobilize to isolate cases (some problems with this) ; the underlying nature of the virus; and how quickly we are able to explore the virus and find a vaccine. For what it’s worthTamiflu (oseltamivir) and Relenza (zanamivir) have been shown to be active against samples of the disease virus.

We have the advantage today of better understanding of viral diseases and a research establishment that may have been primed by the false alarms of the 70’s and the recent SAR’s outbreak. On the other hand our transportation system can spread disease worldwide within a few hours.

From the CDC:

U.S. Human Cases of Swine Flu Infection
State # of laboratory
confirmed cases
California 7 cases
Kansas 2 cases
New York City 8 cases
Ohio 1 case
Texas 2 cases
TOTAL COUNT 20 cases
International Human Cases of Swine Flu Infection
See: World Health Organization
As of April 26, 2009 9:00 AM ET

Stay tuned.

Powered by Zoundry Raven

Progress against cancer–Very Limited and Very Expensive

Gina Kolata’s article in the NY Times (4/24/2009) omits noting the high cost of new approaches to cancer treatment but does highlight the limited progress that has been made.

Over the past 50 years she notes the death rate from cancer has declined only 5% and success in treatment of advanced diseases has been limited.

“With breast cancer, for example, only 20 percent with metastatic disease – cancer that has spread outside the breast, like to bones, brain, lungs or liver – live five years or more, barely changed since the war on cancer began.”

colorectal cancer , only 10 percent with metastatic disease survive five years. That number, too, has hardly changed over the past four decades. The number has long been about 30 percent for metastatic prostate cancer , and in the single digits for lung cancer.”

But the for drug companies financial results have been spectacular. Drugs, even relatively ineffective ones, may be priced at $100,000/year for the drug alone as noted here.

In the rare instance when a drug is effective the cost is even higher. Gleevec (imitinib), developed largely with tax funds for treatment of chronic myelogenous leukemia, is priced by Novartis in the range of $50,000-$100,000/year (depending on stage of disease and indication). These patients may live 10 years or more at a cost of $500,000 to a million dollars for the drug alone. Is this reasonable? It it the best we can do? Can we afford successful treatments?

The problem with cancer is that it is a genetic disease. As one ages and cells divide mistakes in DNA replication occur. These are random, occurring simply because nature isn’t perfect or because of influence of carcinogens. We can try to control the latter but cancer prevention is not simply a matter of smoking cessation (thought that helps) or diet modification and vitamins (they don’t appear to work). We can try to treat but this ordinarily won’t eradicate the genetic cause.

Medicynical note: The letters to the editor in response to the Kolata article are remarkable. Some quite informed. Some with THE answer: a diet cure , pot, homeopathy, diet to lower the body’s pH, etc.

Powered by Zoundry Raven